Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
? Tisagenlecleucel (Kymriah)
? Axicabtagene ciloleucel (Yescarta)
? Brexucabtagene autoleucel (Tecartus)
? Others
PART 6. MARKET BREAKDOWN BY TARGET ANTIGEN
? CD19/CD22
? BCMA (B-cell maturation antigen)
? Others
PART 7. MARKET BREAKDOWN BY REGION
? Asia Pacific
? Europe
? North America
? Rest of the World (RoW)
PART 8. KEY COMPANIES
? AbbVie Inc.
? Amgen Inc.
? AstraZeneca plc
? Autolus Therapeutics plc
? Bellicum Pharmaceuticals, Inc.
? bluebird bio, Inc.
? Bristol-Myers Squibb Company
? CARsgen Therapeutics Co., Ltd.
? Cartesian Therapeutics, Inc.
? Cellectis S.A.
? Celyad Oncology S.A.
? Editas Medicine, Inc.
? Fortress Biotech Inc.
? Gilead Sciences, Inc.
? Janssen Pharmaceuticals, Inc.
? Legend Biotech Corporation
? Mustang Bio, Inc.
? Novartis International AG
? Pfizer Inc.
? PureTech Health plc
? Servier Laboratories?Ltd.
? Takeda Pharmaceutical Company Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER